A Single-blind, Dose-titration Study of KWA-0711 in Patients With Chronic Constipation
Phase of Trial: Phase II
Latest Information Update: 19 Nov 2014
Price : $35 *
At a glance
- Drugs Mizagliflozin (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Kissei Pharmaceutical
- 12 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Sep 2013 New trial record